imipramine has been researched along with Substance Withdrawal Syndrome in 80 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to assess the 12-month cumulative risk of relapse specifically due to discontinuation of imipramine and to test the hypothesis that maintenance treatment with imipramine protects patients with panic disorder and agoraphobia from such reversals." | 9.09 | Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. ( Mavissakalian, MR; Perel, JM, 1999) |
| " We tested if blockade or activation of serotonin (5-HT)(2) receptors affected the time of immobility (as an indirect measure of depression-like behavior) in naïve animals and in those withdrawn from chronic nicotine in the forced swim test (FST)." | 7.76 | Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. ( Filip, M; McCreary, AC; Wydra, K; Zaniewska, M, 2010) |
| " The aim of the present study was to assess the 12-month cumulative risk of relapse specifically due to discontinuation of imipramine and to test the hypothesis that maintenance treatment with imipramine protects patients with panic disorder and agoraphobia from such reversals." | 5.09 | Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. ( Mavissakalian, MR; Perel, JM, 1999) |
| "Forty-eight patients with panic disorder completing 8 months of maintenance treatment with alprazolam (mean dose, 5." | 5.07 | Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
| "In this study adult female Wistar and Wistar-Kyoto (WKY) rats, a putative animal model of depression, were exposed to alcohol vapor 3h daily for 10days (blood alcohol concentration ∼150mg%) followed by daily injection of 10mg/kg of imipramine (IMP, a selective norepinephrine NE/serotonin reuptake inhibitor) or nomifensine (NOMI, a selective NE/dopamine reuptake inhibitor)." | 3.85 | Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants. ( Csoka, AB; Getachew, B; Hauser, SR; Taylor, RE; Tizabi, Y, 2017) |
| "Thus, our results suggest that the reduced IL-4 and IL-10 levels in serum with hippocampal M2 markers may be involved in the stress vulnerability after imipramine discontinuation, and the restoration and modulation of these factors may be useful to some forms of depression-associated conditions." | 3.81 | IL-4/10 prevents stress vulnerability following imipramine discontinuation. ( Choi, HJ; Han, A; Hong, CW; Kim, SH; Kwon, MS; Park, MJ; Yeo, H, 2015) |
| " We tested if blockade or activation of serotonin (5-HT)(2) receptors affected the time of immobility (as an indirect measure of depression-like behavior) in naïve animals and in those withdrawn from chronic nicotine in the forced swim test (FST)." | 3.76 | Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. ( Filip, M; McCreary, AC; Wydra, K; Zaniewska, M, 2010) |
| "The escape behaviour induced in rats by injecting D,L-homocysteic acid (DHL) into the dorsal periaqueductal grey area (DPAG) was used as an animal model of panic attacks to investigate the effect of imipramine, a drug used for the treatment of panic disorder, on the sensitivity of 5-HT1A receptors in the DPAG." | 3.69 | Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. ( Marsden, CA; Mongeau, R, 1997) |
| "Measures of subjective feeling used by five patients indicated that depression of mood occurred about four days after fenfluramine withdrawal." | 3.65 | Drugs of dependence though not of abuse: fenfluramine and imipramine. ( Brezinova, V; Briggs, M; Dunleavy, DL; Lewis, SA; Oswald, I, 1971) |
| "The imipramine effect was greater among nasal users--33% (9/27) response on imipramine vs." | 2.68 | Imipramine treatment of cocaine abuse: possible boundaries of efficacy. ( Klein, DF; Koenig, T; McGrath, PJ; Nunes, EV; Ocepek-Welikson, K; Quitkin, FM; Stewart, JW; Wager, S, 1995) |
| "Imipramine 10 mg/day was the control condition." | 2.67 | Imipramine for the treatment of cocaine and methamphetamine dependence. ( Galloway, GP; Knapp, T; Newmeyer, J; Smith, D; Stalcup, SA, 1994) |
| " Our study indicates that the discontinuation of diazepam, even when given in moderate dosage over a relatively short period of time, may cause withdrawal reactions in combined antidepressant/diazepam treatment." | 2.66 | Withdrawal reactions to diazepam in combined imipramine/diazepam treatment of primary nonagitated depressed outpatients. ( Feet, PO; Larsen, S; Lillevold, PE; Robak, OH, 1988) |
| "Amitriptyline was not found in plasma 14 days after its withdrawal, while at the same time its levels in erythrocytes were still well measurable." | 1.28 | Plasma levels of antidepressants after their withdrawal. ( Beitlová, D; Krulík, R; Príhoda, P; Sikora, J, 1990) |
| "Significant withdrawal symptoms were found over seven symptom categories despite an average tapering period of 6." | 1.26 | Withdrawal symptoms after graduated cessation of imipramine in children. ( Kazdin, AE; Law, W; Petti, TA, 1981) |
| "The authors describe 2 cases in which withdrawal symptoms occurred during the course of imipramine therapy, after the patients had failed to take a single daily dose of medication." | 1.26 | Withdrawal symptoms during the course of imipramine therapy. ( Mendels, J; Stern, SL, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (58.75) | 18.7374 |
| 1990's | 16 (20.00) | 18.2507 |
| 2000's | 12 (15.00) | 29.6817 |
| 2010's | 5 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Getachew, B | 1 |
| Hauser, SR | 1 |
| Csoka, AB | 1 |
| Taylor, RE | 1 |
| Tizabi, Y | 1 |
| Han, A | 1 |
| Yeo, H | 1 |
| Park, MJ | 1 |
| Kim, SH | 1 |
| Choi, HJ | 1 |
| Hong, CW | 1 |
| Kwon, MS | 1 |
| Marszalek-Grabska, M | 1 |
| Gibula-Bruzda, E | 1 |
| Jenda, M | 1 |
| Gawel, K | 1 |
| Kotlinska, JH | 1 |
| Green, AD | 1 |
| Barr, AM | 1 |
| Galea, LA | 1 |
| dos Santos, L | 1 |
| de Andrade, TG | 1 |
| Graeff, FG | 1 |
| Zaniewska, M | 1 |
| McCreary, AC | 1 |
| Wydra, K | 1 |
| Filip, M | 1 |
| D'Aquila, PS | 2 |
| Peana, AT | 1 |
| Panin, F | 2 |
| Grixoni, C | 1 |
| Cossu, M | 1 |
| Serra, G | 2 |
| Mavissakalian, MR | 1 |
| Perel, JM | 1 |
| KRAMER, JC | 1 |
| KLEIN, DF | 2 |
| FINK, M | 1 |
| McMahon, LR | 2 |
| Sell, SL | 2 |
| France, CP | 2 |
| Koek, W | 1 |
| Yoshida, K | 1 |
| Sugawara, Y | 1 |
| Higuchi, H | 1 |
| Harvey, BH | 2 |
| Retief, R | 1 |
| Korff, A | 1 |
| Wegener, G | 1 |
| Simon, P | 1 |
| Telch, MJ | 1 |
| Tearnan, BH | 1 |
| Taylor, CB | 1 |
| Verberne, AJ | 1 |
| Taylor, DA | 1 |
| Fennessy, MR | 1 |
| Dilsaver, SC | 1 |
| Greden, JF | 2 |
| Jones, BD | 1 |
| Steinberg, S | 1 |
| Chouinard, G | 2 |
| Katerndahl, DA | 1 |
| Shrand, H | 1 |
| Law, W | 2 |
| Petti, TA | 2 |
| Kazdin, AE | 1 |
| Boisvert, D | 1 |
| Stern, SL | 1 |
| Mendels, J | 1 |
| Mirin, SM | 1 |
| Schatzberg, AF | 1 |
| Creasey, DE | 1 |
| Fukase, H | 1 |
| Fukuzaki, K | 1 |
| Koja, T | 1 |
| Nagata, R | 1 |
| Lukas, SE | 1 |
| Galloway, GP | 1 |
| Newmeyer, J | 1 |
| Knapp, T | 1 |
| Stalcup, SA | 1 |
| Smith, D | 1 |
| McGrath, PJ | 2 |
| Stewart, JW | 2 |
| Tricamo, E | 1 |
| Nunes, EN | 1 |
| Quitkin, FM | 2 |
| Rickels, K | 2 |
| Schweizer, E | 1 |
| Weiss, S | 1 |
| Zavodnick, S | 1 |
| Nunes, EV | 1 |
| Ocepek-Welikson, K | 1 |
| Koenig, T | 1 |
| Wager, S | 1 |
| Pathiraja, A | 1 |
| Marazziti, D | 1 |
| Cassano, GB | 1 |
| Diamond, BI | 1 |
| Borison, RL | 1 |
| Spanier, C | 1 |
| Frank, E | 1 |
| McEachran, AB | 1 |
| Grochocinski, VJ | 1 |
| Kupfer, DJ | 1 |
| Belej, T | 1 |
| Manji, D | 1 |
| Sioutis, S | 1 |
| Barros, HM | 1 |
| Nobrega, JN | 1 |
| Mongeau, R | 1 |
| Marsden, CA | 1 |
| Perera, M | 1 |
| Khan, MA | 1 |
| DeMartinis, N | 1 |
| García-España, F | 1 |
| Greenblatt, DJ | 1 |
| Mandos, LA | 1 |
| Rynn, M | 1 |
| Sontheimer, DL | 1 |
| Ables, AZ | 1 |
| Altshuler, L | 1 |
| Kiriakos, L | 1 |
| Calcagno, J | 1 |
| Goodman, R | 1 |
| Gitlin, M | 1 |
| Frye, M | 1 |
| Mintz, J | 1 |
| Gupta, R | 2 |
| Gupta, N | 1 |
| Avasthi, A | 1 |
| Jonker, LP | 1 |
| Brand, L | 1 |
| Heenop, M | 1 |
| Stein, DJ | 1 |
| Seltzer, V | 1 |
| Tonge, SR | 1 |
| Kissin, B | 2 |
| Gold, MS | 1 |
| Pottash, AL | 1 |
| Sweeney, DR | 1 |
| Kleber, HD | 1 |
| Redmond, DE | 1 |
| Gardos, G | 1 |
| Kalman, T | 1 |
| Warner, GM | 1 |
| Gire, C | 1 |
| Dubus, JC | 1 |
| Garnier, JM | 1 |
| Unal, D | 1 |
| Babb, SV | 1 |
| Dunlop, SR | 1 |
| Hoffmann, MA | 1 |
| Kusalic, M | 1 |
| Ghadirian, AM | 1 |
| Sikora, J | 1 |
| Krulík, R | 1 |
| Beitlová, D | 1 |
| Príhoda, P | 1 |
| Fellhauer, M | 1 |
| Regan, WM | 1 |
| Margolin, RA | 1 |
| Mathew, RJ | 1 |
| Tandon, R | 1 |
| Dutchak, D | 1 |
| Sunderland, G | 1 |
| Friedman, S | 1 |
| Rosenblum, LA | 1 |
| Eppel, AB | 1 |
| Feet, PO | 1 |
| Larsen, S | 1 |
| Lillevold, PE | 1 |
| Robak, OH | 1 |
| Kishnir, SL | 1 |
| Siris, SG | 1 |
| Strahan, A | 1 |
| Merriam, AE | 2 |
| Ginsberg, HN | 1 |
| Nabeshima, T | 1 |
| Yamaguchi, K | 1 |
| Yoshida, S | 1 |
| Furukawa, H | 1 |
| Kameyama, T | 1 |
| Narang, RL | 1 |
| Burnett, GB | 1 |
| Holland, PJ | 1 |
| Shrivastava, RK | 1 |
| Itil, TM | 1 |
| Eggermont, E | 1 |
| Jhamandas, K | 1 |
| Sutak, M | 1 |
| Bell, S | 1 |
| Avrutskii, GIa | 1 |
| Gurovich, IIa | 1 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 1 |
| Lewis, SA | 2 |
| Oswald, I | 2 |
| Gross, MM | 1 |
| Drew, WG | 1 |
| Chamblin, M | 1 |
| Miller, LL | 1 |
| Kamei, C | 1 |
| Shimomura, K | 1 |
| Ueki, S | 1 |
| Kaneto, H | 1 |
| Koida, M | 1 |
| Tsuchie, F | 1 |
| Sathananthan, GL | 1 |
| Gershon, S | 1 |
| Butterworth, AT | 1 |
| Crisp, AH | 1 |
| Dunleavy, DL | 1 |
| Brezinova, V | 1 |
| Briggs, M | 1 |
| Chiosa, L | 1 |
| Dumitrescu, S | 1 |
| Banaru, A | 1 |
| Dallos, V | 1 |
| Heathfield, K | 1 |
| Shatan, C | 1 |
2 reviews available for imipramine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Antidepressant medication in the treatment of agoraphobia: a critical review.
Topics: Agoraphobia; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine | 1983 |
Antidepressant withdrawal phenomena.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; | 1984 |
8 trials available for imipramine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Antidepressive Agents, Tricyclic; Double-Blind Method; Drug Administration Sched | 1999 |
Imipramine for the treatment of cocaine and methamphetamine dependence.
Topics: Cocaine; Combined Modality Therapy; Counseling; Dose-Response Relationship, Drug; Double-Blind Metho | 1994 |
Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Topics: Adult; Alprazolam; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admi | 1993 |
Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Cocaine; Combined Modality Therapy; Comor | 1995 |
The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: integrating psychological and biological factors.
Topics: Adult; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Female; Fol | 1996 |
Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepin | 2000 |
Withdrawal reactions to diazepam in combined imipramine/diazepam treatment of primary nonagitated depressed outpatients.
Topics: Clinical Trials as Topic; Depressive Disorder; Desipramine; Diazepam; Double-Blind Method; Drug Ther | 1988 |
Depression associated with alcohol withdrawal. Imipramine therapy compared with placebo.
Topics: Adult; Alcoholism; Clinical Trials as Topic; Depression; Diarrhea; Humans; Imipramine; Male; Middle | 1971 |
70 other studies available for imipramine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Role of cortical alpha-2 adrenoceptors in alcohol withdrawal-induced depression and tricyclic antidepressants.
Topics: Animals; Antidepressive Agents, Tricyclic; Blood Alcohol Content; Depression; Disease Models, Animal | 2017 |
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Depression; Electroshock; Expl | 2015 |
Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antidepressive Agents; Central Nervous System S | 2016 |
Role of estradiol withdrawal in 'anhedonic' sucrose consumption: a model of postpartum depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Body Weight; Depression, Postpartum; Disease M | 2009 |
Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Chronic Disease; Diazepam; | 2010 |
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
Topics: Animals; Antidepressive Agents, Tricyclic; Depression; Imipramine; Male; Motor Activity; Neuropsycho | 2010 |
Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Dopamine; Dopamine Agonists; | 2003 |
Withdrawal symptoms following dicontinuation of imipramine therapy.
Topics: Imipramine; Psychopharmacology; Substance Withdrawal Syndrome | 1961 |
Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys.
Topics: Amphetamine; Animals; Biogenic Monoamines; Cocaine; Discrimination Learning; Disease Models, Animal; | 2004 |
Long-term imipramine withdrawal induces a depressive-like behaviour in the forced swimming test.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Depression; Disease Models, Animal; Imi | 2004 |
Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys.
Topics: Adrenergic alpha-Agonists; Amphetamine; Analgesics, Opioid; Animals; Antidepressive Agents, Tricycli | 2005 |
Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants.
Topics: Adult; Antidepressive Agents, Tricyclic; Cabergoline; Depressive Disorder, Major; Dose-Response Rela | 2006 |
Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptors.
Topics: Animals; Antidepressive Agents, Tricyclic; Hippocampus; Imipramine; Male; Nitric Oxide Synthase Type | 2006 |
Antidepressants, benzodiazepines, and convulsions.
Topics: Adult; Anti-Anxiety Agents; Clorazepate Dipotassium; Female; Humans; Imipramine; Seizures; Substance | 1983 |
Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
Topics: Animals; Biogenic Amines; Body Weight; Clomipramine; Dronabinol; Eating; Fluoxetine; Humans; Imipram | 1980 |
Fast-cycling bipolar disorder induced by withdrawal from long-term treatment with a tricyclic antidepressant.
Topics: Bipolar Disorder; Depressive Disorder; Female; Humans; Imipramine; Middle Aged; Substance Withdrawal | 1984 |
Panic.
Topics: Adult; Anxiety Disorders; Cardiovascular Diseases; Endocrine System Diseases; Fear; Female; Humans; | 1982 |
Agoraphobia and imipramine withdrawal?
Topics: Agoraphobia; Female; Humans; Imipramine; Infant, Newborn; Infant, Newborn, Diseases; Phobic Disorder | 1982 |
Withdrawal symptoms after graduated cessation of imipramine in children.
Topics: Anorexia; Child; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; | 1981 |
Abrupt cessation of high-dose imipramine treatment in children.
Topics: Child; Dangerous Behavior; Headache; Humans; Imipramine; Male; Patient Compliance; Sleep Stages; Sub | 1981 |
Rebound cardiac arrhythmia after withdrawal from imipramine: a case report.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Imipramine; Middle Aged; Substance Wit | 1981 |
Withdrawal symptoms during the course of imipramine therapy.
Topics: Adult; Depression; Drug Administration Schedule; Female; Humans; Imipramine; Male; Substance Withdra | 1980 |
Hypomania and mania after withdrawal of tricyclic antidepressants.
Topics: Adult; Affective Disorders, Psychotic; Amitriptyline; Antidepressive Agents, Tricyclic; Bipolar Diso | 1981 |
Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
Topics: Animals; Behavior, Animal; Buprenorphine; Butorphanol; Haloperidol; Imipramine; Macaca fascicularis; | 1994 |
Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; | 1993 |
Phenomenology and neurobiology of cocaine withdrawal: are they related?
Topics: Adult; Affect; Binding, Competitive; Cocaine; Female; Humans; Imipramine; Male; Psychiatric Status R | 1995 |
Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
Topics: Administration, Oral; Animals; Autoradiography; Biological Transport; Brain; Carrier Proteins; Cocai | 1996 |
Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents, Tricyc | 1997 |
Testicular pain and swelling on withdrawal of imipramine.
Topics: Antidepressive Agents, Tricyclic; Edema; Humans; Imipramine; Male; Middle Aged; Pain; Substance With | 1998 |
Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Double-Blind Method | 2001 |
The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
Topics: Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Administrati | 2001 |
Benzodiazepine discontinuation in generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Imipramine; Long-Term Ca | 2002 |
NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Chromatogr | 2002 |
Proceedings: Methylamphetamine withdrawal as a model for the depressive state: antagonism of post-amphetamine depression by imipramine.
Topics: Animals; Brain Chemistry; Depression; Disease Models, Animal; Humans; Imipramine; Male; Methamphetam | 1975 |
The use of psychoactive drugs in the long-term treatment of chronic alcoholics.
Topics: Alcoholism; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Chlordiazepoxide; Chlorpromazine; Ch | 1975 |
Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates.
Topics: Adult; Anxiety; Clonidine; Depression; Drug Therapy, Combination; Fear; Humans; Imipramine; Male; Me | 1979 |
A case of withdrawal dyskinesia.
Topics: Benztropine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Imipramine; Middle Aged; S | 1979 |
Protracted vomiting following abrupt cessation of psychotropics: a case report.
Topics: Adult; Benztropine; Depression; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Male; Sc | 1978 |
[Imipramine withdrawal syndrome during a treatment for enuresis].
Topics: Adolescent; Enuresis; Humans; Imipramine; Male; Substance Withdrawal Syndrome | 1992 |
Protracted ventricular arrhythmias occurring after abrupt tricyclic antidepressant withdrawal.
Topics: Depressive Disorder; Desipramine; Electrocardiography; Humans; Imipramine; Male; Middle Aged; Substa | 1990 |
Paradoxical mood changes during pharmacotherapy of bipolar patients.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Female; Humans; Imipramine; Lithium; Phenelzine; Subst | 1990 |
Plasma levels of antidepressants after their withdrawal.
Topics: Adrenal Glands; Adrenalectomy; Amitriptyline; Animals; Dealkylation; Erythrocytes; Imipramine; Liver | 1990 |
[Drug treatment of nicotine dependence].
Topics: Clonidine; Doxepin; Humans; Imipramine; Mecamylamine; Nicotine; Smoking; Substance Withdrawal Syndro | 1990 |
Cardiac arrhythmia following rapid imipramine withdrawal.
Topics: Bipolar Disorder; Cardiac Complexes, Premature; Electrocardiography; Female; Humans; Imipramine; Lit | 1989 |
Cholinergic syndrome following anticholinergic withdrawal in a schizophrenic patient abusing marijuana.
Topics: Adult; Benztropine; Brain; Humans; Imipramine; Male; Marijuana Abuse; Receptors, Cholinergic; Schizo | 1989 |
Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates.
Topics: Alprazolam; Animals; Anxiety Disorders; Behavior, Animal; Conditioning, Psychological; Fear; Homing | 1989 |
Imipramine and clonazepam for panic disorder.
Topics: Anxiety Disorders; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Fear; Humans; Imipram | 1989 |
Hematemesis following discontinuation of psychoactive drugs in geriatric patients.
Topics: Aged; Chlorpromazine; Female; Haloperidol; Hematemesis; Humans; Imipramine; Male; Procyclidine; Psyc | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psych | 1988 |
Withdrawal NMS after drug treatment.
Topics: Amitriptyline; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Neuroleptic Malignant Syn | 1988 |
Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal.
Topics: Depressive Disorder; Female; Humans; Imipramine; Middle Aged; Propranolol; Restless Legs Syndrome; S | 1986 |
Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment.
Topics: Animals; Behavior, Animal; Imipramine; Male; Mianserin; p-Chloroamphetamine; Phencyclidine; Rats; Ra | 1986 |
Neuroleptic malignant syndrome after imipramine withdrawal.
Topics: Adult; Female; Humans; Imipramine; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1987 |
Mania induced by gradual withdrawal from long-term treatment with imipramine.
Topics: Bipolar Disorder; Depressive Disorder; Humans; Imipramine; Male; Middle Aged; Substance Withdrawal S | 1986 |
Imipramine: withdrawal and urticaria.
Topics: Adult; Female; Humans; Imipramine; Substance Withdrawal Syndrome; Urticaria | 1985 |
Flu-like illness after discontinuance of imipramine.
Topics: Adult; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Nausea; Substance Withdra | 1985 |
Withdrawal symptoms in neonates associated with maternal imipramine therapy.
Topics: Female; Fetus; Humans; Imipramine; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchan | 1973 |
Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms.
Topics: Animals; Atropine; Autonomic Nervous System; Diphenhydramine; Dose-Response Relationship, Drug; Drug | 1973 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
Overdose of tricyclic anti-depressants and deductions concerning their cerebral action.
Topics: Adolescent; Adult; Amitriptyline; Brain; Brain Chemistry; Dreams; Electroencephalography; Female; Hu | 1969 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
Comparison of the effects of cyclazocine and imipramine on the circadian sleep-waking cycle of the cat.
Topics: Administration, Oral; Analgesics; Animals; Azocines; Behavior, Animal; Cats; Circadian Rhythm; Cycla | 1971 |
Significance of withdrawal jumping response in predicting physical dependence in mice.
Topics: Amitriptyline; Animals; Atropine; Cannabis; Chlordiazepoxide; Chlorpromazine; Diazepam; Humans; Imip | 1973 |
[Tolerance and physical dependence producing liability of doxepin].
Topics: Amitriptyline; Animals; Body Weight; Diazepam; Dibenzoxepins; Drug Resistance; Humans; Imipramine; M | 1972 |
Imipramine withdrawal: an akathisia-like syndrome.
Topics: Adult; Anxiety; Brain Chemistry; Dopamine; Female; Humans; Imipramine; Male; Middle Aged; Motor Acti | 1973 |
Slow constant intravenous infusion of imipramine up to 850 mgm/day in patients with affective illness.
Topics: Blood; Depression; Female; Humans; Imipramine; Infusions, Parenteral; Substance Withdrawal Syndrome; | 1966 |
Drugs of dependence though not of abuse: fenfluramine and imipramine.
Topics: Adult; Appetite Depressants; Body Weight; Depression; Dreams; Female; Fenfluramine; Fluorine; Humans | 1971 |
The influence of imipramine on the "abstinence syndrome" to morphine in mice.
Topics: Animals; Humans; Imipramine; Male; Mice; Morphine; Nalorphine; Postural Balance; Substance Withdrawa | 1968 |
Iatrogenic epilepsy due to antidepressant drugs.
Topics: Adolescent; Adult; Alcoholism; Amitriptyline; Antidepressive Agents; Barbiturates; Brain Damage, Chr | 1969 |
Withdrawal symptoms after abrupt termination of imipramine.
Topics: Adult; Depression; Drug Tolerance; Humans; Imipramine; Male; Parent-Child Relations; Personality; Su | 1966 |